News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
863,589 Results
Type
Article (87557)
Company Profile (827)
Press Release (775185)
Multimedia
Podcasts (179)
Webinars (28)
Section
Business (233109)
Career Advice (4140)
Deals (39815)
Drug Delivery (141)
Drug Development (91290)
Employer Resources (203)
FDA (18302)
Job Trends (17407)
News (397512)
Policy (39932)
Tag
Academia (3005)
Academic (2)
Accelerated approval (19)
Adcomms (35)
Allergies (133)
Alliances (56980)
ALS (147)
Alzheimer's disease (1695)
Antibody-drug conjugate (ADC) (269)
Approvals (18344)
Artificial intelligence (522)
Autoimmune disease (109)
Automation (30)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (168)
Biotechnology (485)
Bladder cancer (140)
Brain cancer (53)
Breast cancer (533)
Cancer (4233)
Cardiovascular disease (376)
Career advice (3562)
Career pathing (38)
CAR-T (259)
CDC (57)
Cell therapy (717)
Cervical cancer (33)
Clinical research (75942)
Collaboration (1462)
Company closure (4)
Compensation (982)
Complete response letters (64)
COVID-19 (2966)
CRISPR (87)
C-suite (632)
Cystic fibrosis (142)
Data (5103)
Decentralized trials (2)
Denatured (65)
Depression (115)
Diabetes (472)
Diagnostics (7116)
Digital health (38)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (249)
Drug pricing (196)
Drug shortages (36)
Duchenne muscular dystrophy (210)
Earnings (99482)
Editorial (56)
Employer branding (25)
Employer resources (172)
Events (133694)
Executive appointments (1000)
FDA (20914)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (17)
Funding (1313)
Gene editing (184)
Generative AI (52)
Gene therapy (575)
GLP-1 (1048)
Government (5398)
Grass and pollen (8)
Guidances (375)
Healthcare (20940)
HIV (49)
Huntington's disease (41)
IgA nephropathy (75)
Immunology and inflammation (260)
Immuno-oncology (22)
Indications (61)
Infectious disease (3220)
Inflammatory bowel disease (193)
Inflation Reduction Act (16)
Influenza (104)
Intellectual property (202)
Interviews (816)
IPO (17933)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (82)
Layoffs (643)
Leadership (37)
Legal (10152)
Liver cancer (93)
Longevity (13)
Lung cancer (600)
Lymphoma (290)
Machine learning (33)
Management (66)
Manufacturing (676)
MASH (151)
Medical device (14918)
Medtech (14947)
Mergers & acquisitions (22803)
Metabolic disorders (1217)
Multiple sclerosis (143)
NASH (23)
Neurodegenerative disease (239)
Neuropsychiatric disorders (64)
Neuroscience (2781)
NextGen: Class of 2025 (7707)
Non-profit (5098)
Now hiring (60)
Obesity (585)
Opinion (317)
Ovarian cancer (145)
Pain (173)
Pancreatic cancer (182)
Parkinson's disease (248)
Partnered (32)
Patents (435)
Patient recruitment (345)
Peanut (57)
People (66381)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23424)
Phase II (32955)
Phase III (24851)
Pipeline (3056)
Policy (306)
Postmarket research (3554)
Preclinical (10592)
Press Release (72)
Prostate cancer (207)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (718)
Real estate (7423)
Recruiting (79)
Regulatory (28175)
Reports (65)
Research institute (2700)
Resumes & cover letters (651)
Rett syndrome (18)
RNA editing (15)
RSV (77)
Schizophrenia (140)
Series A (215)
Series B (160)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4320)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (112)
Vaccines (1070)
Venture capital (69)
Weight loss (414)
Women's health (63)
Worklife (21)
Date
Today (170)
Last 7 days (1291)
Last 30 days (3488)
Last 365 days (33564)
2025 (29125)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1284)
Alabama (81)
Alaska (7)
Arizona (312)
Arkansas (14)
Asia (51102)
Australia (8983)
California (10094)
Canada (2968)
China (966)
Colorado (421)
Connecticut (446)
Delaware (290)
Europe (117486)
Florida (1477)
Georgia (327)
Hawaii (3)
Idaho (67)
Illinois (834)
India (56)
Indiana (494)
Iowa (20)
Japan (340)
Kansas (127)
Kentucky (39)
Louisiana (27)
Maine (80)
Maryland (1339)
Massachusetts (7532)
Michigan (321)
Minnesota (594)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (110)
New Hampshire (81)
New Jersey (2783)
New Mexico (32)
New York (2702)
North Carolina (1461)
North Dakota (10)
Northern California (4677)
Ohio (311)
Oklahoma (22)
Oregon (51)
Pennsylvania (2073)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (52)
South Dakota (1)
Southern California (3849)
Tennessee (153)
Texas (1572)
United States (36933)
Utah (301)
Virginia (258)
Washington D.C. (84)
Washington State (856)
West Virginia (4)
Wisconsin (105)
Wyoming (2)
There are 863,589 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System
November 10, 2025
·
9 min read
Press Releases
Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
November 10, 2025
·
5 min read
Press Releases
Data Supporting the Potentially Differentiated Pharvaris Portfolio Presented at ACAAI 2025 Annual Scientific Meeting
November 10, 2025
·
12 min read
Press Releases
Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics
November 10, 2025
·
11 min read
Press Releases
ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray)
November 10, 2025
·
17 min read
Press Releases
Muna Therapeutics Announces First Subjects Dosed in Phase 1 Trial of Novel Oral TREM2 Agonist for Early Alzheimer’s Disease
November 10, 2025
·
3 min read
Press Releases
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - November 7, 2025
November 10, 2025
·
2 min read
Press Releases
HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
November 10, 2025
·
5 min read
Press Releases
Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025
November 10, 2025
·
6 min read
Press Releases
GenVivo to Present Phase 1 Trial Results for GEN2, A Personalizing Systemic Cancer Immunotherapy, at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10, 2025
·
6 min read
1 of 86,359
Next
